Introduction: Entero bacteria are mainly found in the gut of man and animals.\nThe frequent acquisition of antibiotic resistance mechanisms explains\nwhy they are the bacteria most often implicated in human infectious pathology.\nIt is estimated to be involved in 50% of sepsis, 60% of enteritis, 70% of\nurinary tract infection case. Objective: To determine the prevalence of enterobacterial\ninfections diagnosed at Fann Infectious Diseases Clinic, and describe\ntheir epidemiological, clinical, therapeutic and evolutionary aspects.\nPatients and Methods: This is a retrospective and descriptive study, on patients\nhospitalized from January 2013 to December 2014, at Fann Infectious\nDiseases Clinic, with bacteriological confirmation of an enterobacteria infection.\nResults: A total of 129 cases were collected during the study period. The\naverage age was 41 years, and female were predominant (60%) with a sex ratio\nof 0.67. Comorbidity was found in 88.4% of the cases, most of which were\nHIV infection. The most common clinical signs were infectious syndrome\n(53.49%) and general impairment (40.31%). The main gateway was urinary\n(55.8%). Samples were monomicrobial in 76.7% of cases. Klebsiella and\nEscherichia were the most common and 68.7% of the subjects had probabilistic\ntreatment. Most enterobacterial strains were resistant to third generation\ncephalosporins (C3G), aminoglycosides to ciprofloxacin and cotrimoxazole.\nAside from 4% of them, all were sensitive to imipenem. Conclusion: The advent\nof antibiotics has brought hope in the treatment of enterobacterial infections.\nHowever, an increase in their resistance to the usual antibiotics has\nbeen noted in recent years. As a result, the fight against antibiotic resistance\nmust be a priority.
Loading....